A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Title
A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma
Authors
Keywords
-
Journal
Blood Advances
Volume -, Issue -, Pages -
Publisher
American Society of Hematology
Online
2022-02-17
DOI
10.1182/bloodadvances.2021006555

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search